T.HamaA.HienzschA.CaequeT.MllerS.WicinskiJ.et al (2017)
Active cancer or history of malignancy Pregnancy or breastfeeding Known peptide allergies Athletes subject to anti-doping testing (WADA prohibited) Raynauds disease or phenomenon Cold urticaria (hives from cold) Uncontrolled hypertension Peripheral vascular disease Open wounds (for local application) Pregnancy Cardiovascular conditions Diabetes (especially with neuropathy) Current infections Immunosuppression Blood clotting disorders Quality control issues represent perhaps the greatest practical risk with BPC-157
PURITY GURANTEED: L - Carnitine which does NOT CONTAIN fillers, magnesium stearate, dioxides, preservatives, gluten, soy, sugar, yeast, starch, non-GMO.
Asherman Syndrome
The anti-inflammatory properties of peptides like BPC-157 and TB-500 are relevant here, as reducing inflammation in the subacromial space can relieve impingement and allow proper tissue healing
(1969) A preliminary report on the inhalation toxicity of high concentrations of dichlorvos, Sittingbourne, Shell Research Ltd (Unpublished Report TLGR.0024.69)
